Immunotoxin with invivo T cell Suppressant Activity
The invention concerns immunotoxins and methods of using the immunotoxins for the treatment of autoimmune diseases and T cell malignancies. The immunotoxins are targeted via an antibody that is...
View ArticleMethods for Expression and Purification of Immunotoxins
The invention concerns immunotoxins and methods of making the immunotoxins. Targeting of the immunotoxins occurs via an antibody that is specific to T cells. This allows the specific ablation of...
View ArticleXenikos Presents Promising New Data from Expanded Access Program EAP Using...
NIJMEGEN THE NETHERLANDS ACCESSWIRE December 9 2019 Xenikos B.V.75 912 patients achieved clinical response by day 28; five patients achieved complete remission6month overall survival was 75 in the EAP...
View ArticleInnate Pursues AntiLeukemic In EU
Innate Pharma pursues refractory hairy cell leukemia opportunity with firstinclass CD22directed immunotoxin moxetumomab pasudotoxtdfk.&160;&160;&160;
View Article
More Pages to Explore .....
